{Reference Type}: Journal Article
{Title}: Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates.
{Author}: Huang X;Wu D;Zhu L;Wang W;Yang R;Yang J;He Q;Zhu B;You Y;Xiao R;Zhao Z;Huang X;Wu D;Zhu L;Wang W;Yang R;Yang J;He Q;Zhu B;You Y;Xiao R;Zhao Z;
{Journal}: Orphanet J Rare Dis
{Volume}: 17
{Issue}: 1
{Year}: 02 2022 21
{Factor}: 4.303
{DOI}: 10.1186/s13023-022-02231-x
{Abstract}: Newborn screening (NBS) has been implemented for neonatal inborn disorders using various technology platforms, but false-positive and false-negative results are still common. In addition, target diseases of NBS are limited by suitable biomarkers. Here we sought to assess the feasibility of further improving the screening using next-generation sequencing technology.
We designed a newborn genetic sequencing (NBGS) panel based on multiplex PCR and next generation sequencing to analyze 134 genes of 74 inborn disorders, that were validated in 287 samples with previously known mutations. A retrospective cohort of 4986 newborns was analyzed and compared with the biochemical results to evaluate the performance of this panel.
The accuracy of the panel was 99.65% with all samples, and 154 mutations from 287 samples were 100% detected. In 4986 newborns, a total of 113 newborns were detected with biallelic or hemizygous mutations, of which 36 newborns were positive for the same disorder by both NBGS and conventional NBS (C-NBS) and 77 individuals were NBGS positive/C-NBS negative. Importantly, 4 of the 77 newborns were diagnosed currently including 1 newborn with methylmalonic acidemia, 1 newborn with primary systemic carnitine deficiency and 2 newborns with Wilson's disease. A total of 1326 newborns were found to be carriers with an overall carrier rate of 26.6%.
Analysis based on next generation sequencing could effectively identify neonates affected with more congenital disorders. Combined with C-NBS, this approach may improve the early and accurate identification of neonates with inborn disorders. Our study lays the foundation for prospective studies and for implementing NGS-based analysis in NBS.